NCT06447428

Brief Summary

The purpose of this study was to investigate the one-year trajectory of cognitive change in elderly patients with depression, to explore the transfer characteristics and transfer rules of various states of cognitive impairment in patients, to predict the relevant risk factors of cognitive decline, and to find possible influencing factors affecting state change, so as to provide a theoretical basis and reference for subsequent targeted intervention research on geriatric depression.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 24, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 7, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

June 24, 2024

Status Verified

June 1, 2024

Enrollment Period

1.2 years

First QC Date

February 24, 2024

Last Update Submit

June 19, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Montreal cognitive assessment scale (MoCA)

    The Changsha version of the MoCA questionnaire was used in this study, which included eight cognitive assessments of visuospatial and executive functions, naming, memory, attention, speech, abstraction, delayed recall, and orientation, with a total score of 30, with higher scores indicating better cognitive functioning.

    2023.6.1-2024.8.1

  • Subjective cognitive decline questionnaire (SCD questionnaire 9, SCD-9)

    The SCD-9 is mainly used to distinguish between normal people and SCD patients. The scale mainly consists of 2 dimensions, i.e., overall memory ability and time comparison (4 entries) and daily activity ability (5 entries), with a total of 9 entries, and the total scale score ranges from 0 to 9, with higher scores indicating a more severe degree of SCD.

    2023.6.1-2024.8.1

Secondary Outcomes (8)

  • Activities of Daily Living (ADL)

    2023.6.1-2024.8.1

  • general information

    2023.6.1-2024.8.1

  • Self Rating Anxiety Scale (SAS)

    2023.6.1-2024.8.1

  • Social Support Rating Scale (SSRS)

    2023.6.1-2024.8.1

  • Lubben Social Network Scale (LSNS-6)

    2023.6.1-2024.8.1

  • +3 more secondary outcomes

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Elderly patients with depression who met the inclusion and exclusion criteria were selected from a number of nursing facilities, hospitals and communities

You may qualify if:

  • meeting the criteria for major depression in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
  • age at first onset ≥60 years
  • Informed consent

You may not qualify if:

  • Relevant past history affecting cognitive function: various types of stroke, traumatic brain injury, severe brain atrophy, mental abnormalities
  • Perennial alcohol addiction, or long-term use of various drugs that affect mental state
  • Survival time of malignant tumors and tumors
  • Patients with language, vision, and hearing impairments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fujian Medial University

Fuzhou, Fujian, 350100, China

RECRUITING

Study Officials

  • Ziping Zhu

    Fujian Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 24, 2024

First Posted

June 7, 2024

Study Start

June 1, 2023

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

June 24, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will share

Participant characteristics (e.g. age, gender, etc.), medical history (e.g. history of diabetes, hypertension, etc.), clinical outcomes (e.g. death), participation of patients at each stage, loss to follow-up rate

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
2025.6-2026.6
Access Criteria
To obtain the data, you need to send an email address to the researcher himself

Locations